OTC Medicines

Browse OTC Medicines Content

CHPA and its member companies strongly support the OTC Monograph System, which effectively and efficiently regulates the majority of OTC medicines on the U.S. market.

Mar 25, 2014

The members of the stakeholder selection committee respectfully submit these candidates to serve as the non-voting industry representative and alternate (as needed) for the FDA Pediatric Advisory Committee.

Nov 14, 2013

Summary and recommendations from The Gerontological Society of America and Consumer Healthcare Products Association National Summit on Over-the-Counter Medication Behaviors of Older Adults.

Oct 1, 2013

CHPA requests that FDA publish a statement of enforcement policy expressly permitting manufacturers of single-ingredient acetaminophen OTC drugs subject to the ongoing internal analgesic, antipyretic, and antirheumatic monograph proceedings to including labeling on products that provide instructions for use in children aged six months to two years.

Aug 15, 2013

CHPA's comments on this Draft Guidance are organized into three General Comments and Detailed Comments by Section.

Aug 12, 2013

CHPA supports advancing modernization of USP's quality monographs, updating and improving the compendial test methods and establishing product standards which can provide an additional measure of safety for OTC products.

Jul 31, 2013

Filter Results